Eric Lefkofsky is the Chief Executive Officer and Co-Founder of Tempus. The primary purpose of why he built his company is that he would want physicians to be able to provide treatment methods and customized cancer care for their patients through the use of a machine that has an interactive and analytical platform. Lefkofsky was able to attend an established and independent conference that was also attended by notable biotechnology experts and remarkable psychiatrists across the globe. During the Precision Medicine World Conference or PMWC, Eric Lefkofsky and fellow biotechnology experts were exposed in various aspects and directions regarding precision medicine. The conference had over 2,000 speakers, 2,500 companies, and 13,000 people were able to attend.
In the Question and Answer Portion, Eric Lefkofsky was able to showcase and talk about his company throughout the audience. He stated company Tempus will be taking advantage of technological advancements and recent medical human genome sequencing and further scientific research along with other medical professionals. There are various treatments that can be provided to cancer patient and the main point is that there is simply a lack of facts and statistics for guided treatments. Lefkofsky also said that he wants to stop this issue because it is not possible to treat a patient without the advantages of present-day software and data.
It can be seen that Biotechnology is Eric Lefkofsky’s passion in life and it is a trend that has been exciting for him for years now. According to Eric Lefkofsky, Biotechnology has the ability to shift from time to time and can be developed for complex ways in terms of treatment and care. He sees a future wherein Biotechnology has the ability to help people in many ways. He wants fellow doctors to be able to apply a modern, upscale, and advanced technology in helping patients as well as providing the right and precise data for treatments. Eric Lefkofsky is a man who is not afraid to take risks, to constantly evolve, and to be brave in his field. He uses his strengths to come up with a solution that is beneficial to people in the long run.
Eric Lefkofsky is the co-founder and the current chief executive officer of Tempus, a firm that aims to provide technology enabled precision medicine solutions. Its principal mission is to provide the tools and technology that will enable the growth of precision medicine. The firm is consists of medical as well as business specialists that work together in the goal to improve patient outcomes.
Tempus is a company that hosts the biggest library of clinical and molecular data. In addition to this database, the company led by Eric Lefkofsky also uses an operating system that enables management and access to useful information from the database. The information stored is only available for the patient, physicians, and researchers. Lefkofsky co-founded the company with Brad Keywell in 2015 and is currently based in Chicago, Illinois. In 2017, the company secured financing that amounts to $130 million after a $70 million Series C funding from New Enterprise Associates.
The technology that Tempus uses is the data sequencing in which Eric Lefkofsky explain in his interview via Fortune. According to his interview statements, data sequencing is the managing data from patients and using the data gathered for future treatments with the same case. Physicians and doctors will also be able to use the data to know related treatments. The storage of clinical and molecular data is supported by big names in tech by helping in the development of AI that will help in the fast retrieval of stored data.
Eric Lefkofsky is not only known for his co-founding of Tempus. He is also known for his other entrepreneurial ventures such as InnerWorkings, which provide print procurement services and was co-founded in fall 2011. Lefkofsky stayed in the company’s board of directors until 2012. He is also a co-founder of Echo Global Logistics in 2005. Echo went public after New Enterprise Associates provided financing.
In addition to his entrepreneurial ventures, Eric Lefkofsky is also known for his philanthropic endeavors, teaching, and writing careers. He and his wife created the Lefkofsky Foundation in 2006. The foundation already helped more than 50 organizations and is focused on helping children. He is also a member of The Giving Pledge, a pro-poor campaign that covers over 22 countries. He also taught Applied Technology at DePaul University’s Kellstadt Graduate School of Business.
Eric Lefkofsky is no stranger to success. Co- founder and chairman of Groupon, and co-founder of the leading provider of integrated media procurement technology, Mediaocean, he has found infinite success in technology and using technology to help people and make the lives of others easier. He is currently CEO of Tempus, which is a technology company that contains the world’s largest library of clinical molecular data and a system that makes data accessible and useful to physicians. Tempus was built to use historical data to help with treatment of terminal illnesses, with cancer as its priority.
Lefkofsky is a strong believer in making big strides in industries that have otherwise remained stagnant and consistent as revealed in his book Accelerated Disruption: Understanding the True Speed of Innovation. In this book, Lefkofsky emphasizes the importance of choosing the right industries to innovate and developing right strategies. These techniques are what led him to earning $1.79 billion over the years in technology innovation within e-commerce and startups. His history with these publicly-traded companies has brought him to the point of being able to create Tempus for the betterment of society and to disrupt the medical industry as we all know it.
Prior to the creation of Tempus, Lefkofsky noticed that the technology was advancing in all other industries except for the most important one—the medical industry. Physicians were collecting large amounts of data on patients dealing with terminal illnesses without having a way to properly analyze it in a way that will help other patients with similar symptoms in the future. Other startups have stepped in to try to improve the medical industry through technology, but Tempus has the industrial connections and capital to make a big difference.
Eric Lefkofsky has successfully been able to communicate with prestigious hospitals and partner with them in hopes of obtaining immense amounts of data. They have also secured lab space in which they will be able to perform tests for gene-sequencing. With the software provided by Tempus, physicians will be able to use the data to make analyses to assist with treatment for a large number of future patients.